Tacrolimus-eluting carbon-coated stents versus sirolimus-eluting stents for prevention of symptom-driven clinical end points

Clinical Research in Cardiology

Volumn 99, Issue 10, 2010, Pages 645-650

  Siller Matula, J M ^b   Tentzeris, I ^a   Vogel, B ^a   Schacherl, S ^a   Jarai, R ^a   Geppert, A ^a   Unger, G ^a   Huber, K ^a  

^a WILHELMINEN HOSPITAL   (Austria)

^b NONE

Author keywords

Active coating; Carbon; CYPHER ; Drug eluting stents; JANUS ; Passive coating

Indexed keywords

RAPAMYCIN; TACROLIMUS;

ADULT; ARTICLE; COMPARATIVE STUDY; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; IN-STENT RESTENOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; REVASCULARIZATION; RISK FACTOR;

AGED; ANGIOPLASTY, BALLOON, CORONARY; CARBON; CARDIOVASCULAR DISEASES; CORONARY DISEASE; DRUG-ELUTING STENTS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; REGISTRIES; SIROLIMUS; TACROLIMUS; TREATMENT OUTCOME;

EID: 77957879653     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-010-0165-3     Document Type: Article

References (27)

1. R Lowe IB Menown G Nogareda IM Penn 2005 Coronary stents: in these days of climate change should all stents wear coats? Heart 91 Suppl 3 iii20 iii23 10.1136/hrt.2005.060269 15919648 (Pubitemid 40769248)
2. KW Lau KH Mak JS Hung U Sigwart 2004 Clinical impact of stent construction and design in percutaneous coronary intervention Am Heart J 147 5 764 773 10.1016/j.ahj.2003.12.007 15131529 (Pubitemid 38880980)
3. B Scheller M Kuhler B Cremers D Mahnkopf M Bohm M Boxberger 2008 Short- and long-term effects of a novel paclitaxel coated stent in the porcine coronary model Clin Res Cardiol 97 2 118 123 10.1007/s00392-007-0597-6 18087665 (Pubitemid 351257996)
4. H Wieneke T Sawitowski S Wnendt A Fischer O Dirsch IA Karoussos R Erbel 2002 Stent coating: a new approach in interventional cardiology Herz 27 6 518 526 10.1007/s00059-002-2405-4 12378397
5. B Cremers M Biedermann D Mahnkopf M Bohm B Scheller 2009 Comparison of two different paclitaxel-coated balloon catheters in the porcine coronary restenosis model Clin Res Cardiol 98 5 325 330 1:CAS:528:DC%2BD1MXlt1Kjuro%3D 10.1007/s00392-009-0008-2 19280084
6. E Romagnoli AM Leone F Burzotta C Trani G Angeloni G Materazzo G Niccoli V de Maria M Perfetti MA Mazzari R Mongiardo AG Rebuzzi G Schiavoni F Crea 2008 Outcomes of the tacrolimus drug-eluting Janus stent: a prospective two-centre registry in high-risk patients J Cardiovasc Med (Hagerstown) 9 6 94 589
7. R Zahn CW Hamm U Zeymer G Richardt M Kelm B Levenson T Bonzel U Tebbe G Sabin CA Nienaber T Pfannebecker J Senges 2009 Coronary stenting with the sirolimus-eluting stent in patients with restenosis after intracoronary brachytherapy: results from the prospective multicentre German Cypher stent registry Clin Res Cardiol 99 99 106 10.1007/s00392-009-0088-z 19882098
8. H Mollmann A Elsasser H Nef S Schneider CA Nienaber G Richardt M Weber M Kelm B Levenson T Bonzel U Tebbe G Sabin T Pfannebecker J Senges CW Hamm 2008 Treatment of in-stent restenosis with sirolimus-eluting-stents: results from the prospective German Cypher stent registry Clin Res Cardiol 97 7 432 440 10.1007/s00392-008-0646-9 18317669
9. AL Bartorelli D Trabattoni F Fabbiocchi P Montorsi S de Martini G Calligaris G Teruzzi S Galli P Ravagnani 2003 Synergy of passive coating and targeted drug delivery: the tacrolimus-eluting Janus CarboStent J Interv Cardiol 16 6 499 505 10.1046/j.1540-8183.2003.01050.x 14632947 (Pubitemid 37431017)
10. I De Scheerder M Szilard H Yanming XB Ping E Verbeken D Neerinck E Demeyere W Coppens F Van de Werf 2000 Evaluation of the biocompatibility of two new diamond-like stent coatings (Dylyn) in a porcine coronary stent model J Invasive Cardiol 12 8 389 394 10953100
11. K Gutensohn C Beythien J Bau T Fenner P Grewe R Koester K Padmanaban P Kuehnl 2000 In vitro analyses of diamond-like carbon coated stents. Reduction of metal ion release, platelet activation, and thrombogenicity Thromb Res 99 6 85 577 10.1016/S0049-3848(00)00295-4 (Pubitemid 30642739)
12. S Linder W Pinkowski M Aepfelbacher 2002 Adhesion, cytoskeletal architecture and activation status of primary human macrophages on a diamond-like carbon coated surface Biomaterials 23 3 767 773 1:CAS:528:DC%2BD3MXosFKms7c%3D 10.1016/S0142-9612(01)00182-X 11771697 (Pubitemid 33108952)
13. D Antoniucci A Bartorelli R Valenti P Montorsi GM Santoro F Fabbiocchi L Bolognese A Loaldi M Trapani D Trabattoni G Moschi S Galli 2000 Clinical and angiographic outcome after coronary arterial stenting with the carbostent Am J Cardiol 85 7 821 825 1:STN:280:DC%2BD3c3itVKhsw%3D%3D 10.1016/S0002-9149(99) 00874-7 10758920 (Pubitemid 30157846)
14. D Antoniucci R Valenti A Migliorini G Moschi M Trapani L Bolognese GM Santoro G Cerisano 2001 Clinical and angiographic outcomes following elective implantation of the carbostent in patients at high risk of restenosis and target vessel failure Catheter Cardiovasc Interv 54 4 420 426 1:STN:280: DC%2BD3Mnps12ntA%3D%3D 10.1002/ccd.2004 11747173 (Pubitemid 33095800)
15. AL Bartorelli D Trabattoni P Montorsi F Fabbiocchi S Galli P Ravagnani L Grancini S Cozzi A Loaldi 2002 Aspirin alone antiplatelet regimen after intracoronary placement of the Carbostent: the ANTARES study Catheter Cardiovasc Interv 55 2 150 156 10.1002/ccd.10037 11835638 (Pubitemid 34127371)
16. F Airoldi A Colombo D Tavano G Stankovic S Klugmann V Paolillo E Bonizzoni C Briguori M Carlino M Montorfano F Liistro A Castelli A Ferrari F Sgura C Di Mario 2004 Comparison of diamond-like carbon-coated stents versus uncoated stainless steel stents in coronary artery disease Am J Cardiol 93 4 474 477 1:CAS:528:DC%2BD2cXht1yqs7k%3D 10.1016/j.amjcard.2003.10.048 14969628 (Pubitemid 38221362)
17. J Haase H Storger M Hofmann CE Schwarz H Reinemer F Schwarz 2003 Comparison of stainless steel stents coated with turbostratic carbon and uncoated stents for percutaneous coronary interventions J Invasive Cardiol 15 10 562 565 14519887
18. AT Ong PW Serruys J Aoki A Hoye CA van Mieghem GA Rodriguez-Granillo M Valgimigli K Sonnenschein E Regar M van der Ent PP de Jaegere EP McFadden G Sianos WJ van der Giessen PJ de Feyter RT van Domburg 2005 The unrestricted use of paclitaxel- versus sirolimus-eluting stents for coronary artery disease in an unselected population: one-year results of the taxus-stent evaluated at Rotterdam Cardiology Hospital (T-SEARCH) registry J Am Coll Cardiol 45 7 1135 1141 1:CAS:528:DC%2BD2MXivV2gsrw%3D 10.1016/j.jacc.2005.01.008 15808774 (Pubitemid 40432449)
19. J Garcia-Tejada H Gutierrez A Albarran F Hernandez T Velazquez S Rodriguez I Gomez J Tascon 2007 Janus tacrolimus-eluting carbostent. Immediate and medium-term clinical results Rev Esp Cardiol 60 2 197 200 10.1157/13099467 17338885 (Pubitemid 46566974)
20. C Tamburino ME Di Salvo D Capodanno P Capranzano R Parisi F Mirabella F Scardaci G Ussia AR Galassi D Fiscella R Mehran G Dangas 2009 Real world safety and efficacy of the Janus tacrolimus-eluting stent: long-term clinical outcome and angiographic findings from the tacrolimus-eluting stent (TEST) registry Catheter Cardiovasc Interv 73 2 243 248 10.1002/ccd.21750 19156896
21. A Rinker T Nusser G Grossmann W Koenig J Wohrle 2008 Angiographic results of a Tacrolimus-eluting stent in acute coronary syndrome lesions Clin Res Cardiol 98 2 89 93 10.1007/s00392-008-0726-x 18853086
22. Trabattoni D, Antoniucci D, Fabbiocchi F, Valenti R, Montrosi P, Migliorini A (2003) First clinical experience with the tacrolimus-eluting Janus carbostent in de-novo coronary arteries: the JUPITER I study. Oral presentation at Transcatheter Cardiovascular Therapeutics 2003
23. M Morice HP Bestehorn D Carrie C Macaya W Aengevaeren W Wijns C Dubois R De Winter S Verheje S Hoffmann O Pachinger C Di Mario 2006 Direct stenting of de novo coronary stenoses with tacrolimus-eluting versus carbon-coated carbostent. The randomized Jupiter II trial EuroInterv 2 45 52
24. YL Han SL Wang QM Jing HB Yu B Wang YY Ma B Luan G Wang 2007 Midterm outcomes of prospective, randomized, single-center study of the Janus tacrolimus-eluting stent for treatment of native coronary artery lesions Chin Med J (Engl) 120 7 552 556
25. CL Grines RO Bonow DE Casey Jr TJ Gardner PB Lockhart DJ Moliterno P O'Gara P Whitlow 2007 Prevention of premature discontinuation of dual of antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College Physicians J Am Coll Cardiol 49 6 734 739 1:CAS:528:DC%2BD2sXhs1SltLw%3D 10.1016/j.jacc.2007.01.003 17291948 (Pubitemid 46210116)
26. B Scheller A Grandt S Wnendt G Lorenz M Bohm G Nickenig 2005 Comparative study of tacrolimus and paclitaxel stent coating in the porcine coronary model Z Kardiol 94 7 445 452 1:CAS:528:DC%2BD2MXns1SitLo%3D 10.1007/s00392-005-0237-y 15997345 (Pubitemid 40956671)
27. AL Bartorelli C Tamburino D Trabattoni A Galassi R Serdoz I Sheiban G Piovaccari M Zimarino A Benassi C Di Mario P Sangiorgio S Chierchia B Reimers 2007 Comparison of two antiplatelet regimens (aspirin alone versus aspirin + ticlopidine or clopidogrel) after intracoronary implantation of a carbofilm-coated stent Am J Cardiol 99 8 1062 1066 1:CAS:528: DC%2BD2sXktF2msLw%3D 10.1016/j.amjcard.2006.11.067 17437728 (Pubitemid 46560469)